Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Mar 14, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Staar Surgical Co
|
0
|
—
|
—
|
—
|
0
|
Mar 12
| |||||||
Staar Surgical Co
| 2.61K |
—
|
—
| +6.10% | 45.48K |
Mar 7
| |||||||
Biorestorative Therapies, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 13
| |||||||
Staar Surgical Co
| 2.58K |
$44.10 | -$111,969.90 | +6.41% | 42.86K |
Aug 10
| |||||||
Staar Surgical Co
| 3.13K |
$54.79 | -$108,867.73 | +7.41% | 45.4K |
Jun 6
| |||||||
Staar Surgical Co
| 11.89K |
$56.63 | -$16,366.07 | +35.21% | 45.68K |
Mar 10
| |||||||
Staar Surgical Co
| 648 |
$58.13 | $37,668.24 | +1.86% | 35.49K |
Mar 7
| |||||||
Biorestorative Therapies, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 17
| |||||||
Biorestorative Therapies, Inc.
|
0
|
—
|
—
|
—
|
0
|
Nov 3
| |||||||
Staar Surgical Co
| 5.12K |
—
|
—
| +17.23% | 34.84K |
Jun 7
| |||||||
Staar Surgical Co
| 9.22K |
—
|
—
| +36.01% | 34.84K |
Mar 7
| |||||||
Biorestorative Therapies, Inc.
|
0
|
—
|
—
|
—
|
0
|
Nov 4
| |||||||
Biorestorative Therapies, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Staar Surgical Co
| -5.12K |
$139.38 | -$713,764.98 | -16.66% | 25.62K |
Sep 16
| |||||||
Staar Surgical Co
| 2.62K |
$140.58 | -$351,450.00 | +9.32% | 30.74K |
Aug 10 - Aug 11
| |||||||
Staar Surgical Co
| 2.51K |
—
|
—
| +8.18% | 33.24K |
Mar 12
| |||||||
Staar Surgical Co
| 30.73K |
—
|
—
|
∞
| 30.73K |
Aug 10
| |||||||
Staar Surgical Co
|
0
|
—
|
—
|
—
|
0
| ||||||||
Sientra, Inc.
| 80K |
$20.97 | $1,677,600.00 | +126.03% | 143.47K |
Aug 6
| |||||||
Sientra, Inc.
| 7.41K |
$13.50 | $100,008.00 | +14.82% | 57.41K |
May 7
| |||||||
Sientra, Inc.
| 50K |
—
|
—
|
∞
| 50K |
Jan 19
| |||||||
Sientra, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
Zeltiq Aesthetics Inc
| -3.98K |
$20.69 | -$82,449.65 | -5.17% | 73.12K |
Feb 19 - Feb 21
| |||||||
Zeltiq Aesthetics Inc
| -9.78K |
$29.53 | -$288,891.99 | -11.33% | 76.58K |
Nov 19
| |||||||
Zeltiq Aesthetics Inc
|
0
|
$19.58 | -$448,576.00 |
—
| 86.36K |
Aug 7
|
Scheduled
| ||||||
Zeltiq Aesthetics Inc
| -7.04K |
$17.31 | -$592,075.84 | -7.54% | 86.36K |
Jun 17
|
Scheduled
| ||||||
Zeltiq Aesthetics Inc
| 18.48K |
$34.23 | -$64,318.17 | +24.86% | 92.84K |
Feb 19 - Feb 21
| |||||||
Zeltiq Aesthetics Inc
| -1.60K |
$17.42 | -$273,551.92 | -2.11% | 74.35K |
Jan 9
|
Scheduled
| ||||||
Zeltiq Aesthetics Inc
| -900.00 |
$17.31 | -$57,456.50 | -1.17% | 75.95K |
Dec 18
|
Scheduled
| ||||||
Zeltiq Aesthetics Inc
| -15.78K |
$16.46 | -$564,978.90 | -17.19% | 76.01K |
Nov 19 - Nov 20
|
Scheduled
| ||||||
Zeltiq Aesthetics Inc
| -500.00 |
$15.05 | -$169,226.10 | -0.54% | 91.8K | +1 |
Sep 11
|
Scheduled
| |||||
Zeltiq Aesthetics Inc
|
0
|
$13.39 | -$43,827.41 |
—
| 92.3K | +1 |
Sep 2
|
Scheduled
| |||||
Zeltiq Aesthetics Inc
| -500.00 |
$21.13 | -$10,563.00 | -0.54% | 92.3K | +1 |
Jul 30
|
Scheduled
| |||||
Zeltiq Aesthetics Inc
| -1.00K |
$17.17 | -$17,166.60 | -1.07% | 92.8K | +1 |
Jun 2
|
Scheduled
| |||||
Zeltiq Aesthetics Inc
|
0
|
$12.44 | -$78,186.50 |
—
| 87.95K | +1 |
Apr 1
|
Scheduled
| |||||
Zeltiq Aesthetics Inc
| 20K |
—
|
—
| +29.43% | 87.95K | +1 |
Feb 21
| ||||||
Zeltiq Aesthetics Inc
| -7.05K |
$14.99 | -$105,619.54 | -9.39% | 67.95K | +1 |
Nov 19
| ||||||
Zeltiq Aesthetics Inc
| 75K |
—
|
—
|
∞
| 75K |
Nov 19
| |||||||
Zeltiq Aesthetics Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.